Isofraxidin
CAS No. 486-21-5
Isofraxidin ( Isofraxidin; Phytodolor )
Catalog No. M18627 CAS No. 486-21-5
Isofraxidin protects leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 43 | In Stock |
|
10MG | 74 | In Stock |
|
25MG | 151 | In Stock |
|
50MG | 227 | In Stock |
|
100MG | 340 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsofraxidin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsofraxidin protects leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner.
-
DescriptionIsofraxidin protects leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner. Isofraxidin has a protective effect against LPS-induced ALI, and the protective effect of Isofraxidin seems to result from the inhibition of COX-2 protein expression in the lung, which regulates the production of PGE2. Isofraxidin possesses significant analgesic and anti-inflammatory activities that may be mediated through the regulation of pro-inflammatory cytokines, TNF-α and the phosphorylation of p38 and ERK1/2.
-
SynonymsIsofraxidin; Phytodolor
-
PathwayOthers
-
TargetOther Targets
-
Recptorp38;ERK
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number486-21-5
-
Formula Weight222.19
-
Molecular FormulaC11H10O5
-
Purity98%
-
Solubility——
-
SMILESCOC1=C(C(=C2C(=C1)C=CC(=O)O2)OC)O
-
Chemical Name7-Hydroxy-6,8-dimethoxychromen-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Proinsulin C-Peptide...
Human proinsulin, the single-chain peptide precursor of insulin, consists of the insulin A and B chains connected by the 31 amino acid C-peptide. Cleavage of proinsulin by proteolytic enzymes produces insulin and free C-peptide.
-
TGN020
TGN-020 is an inhibitor of Aquaporin 4 (AQP4 IC50: 3.1 μM) the most abundant water channel in the brain.
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.